BioPharma Dive - Latest News

GlycoEra raises $130M, riding interest in protein degraders

The startup is the latest beneficiary of investors’ appetite for protein-degrading technology, which offers a way to reach drug targets other technologies can’t.

May 27, 2025 - 17:30
 0
GlycoEra raises $130M, riding interest in protein degraders

The startup is the latest beneficiary of investors’ appetite for protein-degrading technology, which offers a way to reach drug targets other technologies can’t.

Read More

Tags:

Previous Article

Patient dies in trial of Rocket gene therapy for heart condition

Next Article

RFK Jr. rolls back Covid vaccine recommendations for healthy children, pregnant ...

Related Posts

Zepzelca, Tecentriq combo extends survival in hard-to-treat lung cancer

Zepzelca, Tecentriq combo extends survival in hard-to-t...

May 22, 2025  0

FDA sets stricter approval standards for COVID vaccines

FDA sets stricter approval standards for COVID vaccines

May 20, 2025  0

Regeneron wins bid to buy 23andMe out of bankruptcy

Regeneron wins bid to buy 23andMe out of bankruptcy

May 19, 2025  0